Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.
Janssen JBE, Brahm CG, Driessen CML, Nuver J, Labots M, Kouwenhoven MCM, Sanchez Aliaga E, Enting RH, de Groot JC, Walenkamp AME, van Linde ME, Verheul HMW. Janssen JBE, et al. Among authors: labots m. Brain Commun. 2024 Jul 30;6(4):fcae241. doi: 10.1093/braincomms/fcae241. eCollection 2024. Brain Commun. 2024. PMID: 39114330 Free PMC article. Clinical Trial.
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.
van Duin IAJ, Schuiveling M, Ter Maat LS, Veta M, van Eijs MJM, Verheijden RJ, van den Berkmortel FWPJ, Boers-Sonderen MJ, Hospers GAP, Labots M, de Groot JWB, Kapiteijn E, Piersma D, Vreugdenhil G, Westgeest H, Schrader AMR, van Diest PJ, Blokx WAM, Suijkerbuijk KPM. van Duin IAJ, et al. Among authors: labots m. Immunooncol Technol. 2024 Jun 12;24:100714. doi: 10.1016/j.iotech.2024.100714. eCollection 2024 Dec. Immunooncol Technol. 2024. PMID: 39045171 Free PMC article.
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol.
Zeverijn LJ, Geurts BS, Battaglia TW, van Berge Henegouwen JM, de Wit GF, Hoes LR, van der Wijngaart H, van der Noort V, Roepman P, de Leng WWJ, Jansen AML, Chalabi M, van Herpen CML, Devriese LA, Erdkamp FLG, Labots M, de Jonge MJA, Kerver ED, Bins AD, Leek LVM, Notohardjo JCL, van den Eertwegh AJM, Wessels LFA, Verheul HMW, Gelderblom H, van de Haar J, Voest EE. Zeverijn LJ, et al. Among authors: labots m. Clin Cancer Res. 2024 Oct 1;30(19):4339-4351. doi: 10.1158/1078-0432.CCR-24-0480. Clin Cancer Res. 2024. PMID: 39024037
63 results